180 related articles for article (PubMed ID: 11866260)
1. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus.
Sampliner RE; Camargo L; Fass R
Am J Gastroenterol; 2002 Feb; 97(2):270-2. PubMed ID: 11866260
[TBL] [Abstract][Full Text] [Related]
2. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.
Sharma P; Wani S; Weston AP; Bansal A; Hall M; Mathur S; Prasad A; Sampliner RE
Gut; 2006 Sep; 55(9):1233-9. PubMed ID: 16905695
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
[TBL] [Abstract][Full Text] [Related]
5. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus.
Fass R; Garewal HS; Hayden CW; Ramsey L; Sampliner RE
Gastrointest Endosc; 2001 Jun; 53(7):711-6. PubMed ID: 11375576
[TBL] [Abstract][Full Text] [Related]
6. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
[TBL] [Abstract][Full Text] [Related]
7. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
8. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
Ouatu-Lascar R; Triadafilopoulos G
Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
[TBL] [Abstract][Full Text] [Related]
10. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results.
Sampliner RE; Fennerty B; Garewal HS
Gastrointest Endosc; 1996 Nov; 44(5):532-5. PubMed ID: 8934157
[TBL] [Abstract][Full Text] [Related]
11. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
12. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Cooper BT; Chapman W; Neumann CS; Gearty JC
Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
[TBL] [Abstract][Full Text] [Related]
13. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
Sampliner RE
Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
[TBL] [Abstract][Full Text] [Related]
14. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study].
Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF
Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363
[TBL] [Abstract][Full Text] [Related]
16. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
Katzka DA; Castell DO
Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
[TBL] [Abstract][Full Text] [Related]
17. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
18. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
19. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
20. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Menges M; Müller M; Zeitz M
Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]